The Frugal Body: How India Is Building Space Medicine on a Budget

When India's Mars Orbiter Mission reached the red planet in September 2014 at a total cost of approximately 450 crore rupees, roughly 74 million US dollars, the achievement was celebrated worldwide as proof that space exploration need not cost billions. ISRO had done with a fraction of NASA's budget what only three other agencies had managed before. But Mangalyaan was a spacecraft, not a crew capsule. It carried instruments, not people. And the distance between orbiting Mars with a probe and sending Indians to deep space is not measured in kilometres. It is measured in the biology of the human body.

With Gaganyaan, India's first crewed spaceflight program, ISRO is now confronting the medical dimension of human spaceflight for the first time. The challenges are the same ones every space agency faces: bone loss, muscle atrophy, cardiovascular deconditioning, radiation exposure. But India's approach to solving them reflects the same philosophy that got Mangalyaan to Mars. Build smart. Build lean. Build for the constraints you have, not the budget you wish you had.

Gaganyaan and the Birth of Indian Space Medicine

Gaganyaan, approved by the Indian government in 2018 with a budget of approximately 10,000 crore rupees (around 1.2 billion US dollars), aims to send a three-person crew to low Earth orbit for a mission of up to seven days. The program represents a qualitative leap for ISRO, from an agency that builds and launches satellites to one that must keep human beings alive in the most hostile environment accessible to technology.

The crew health dimension of Gaganyaan is managed through a collaboration between ISRO and the Indian Armed Forces' Institute of Aerospace Medicine in Bangalore. IAM, part of the Indian Air Force, has decades of experience in aviation medicine and pilot selection. The extension to space medicine required new capabilities in areas that have no precedent in Indian aerospace: microgravity physiology, space radiation biology, and closed-loop life support systems.

Four Indian Air Force pilots were selected as Gaganyaan astronaut candidates in 2020. They underwent basic spaceflight training at the Yuri Gagarin Cosmonaut Training Centre in Star City, Russia, building on India's longstanding space cooperation with Russia that dates back to Rakesh Sharma's 1984 Soyuz flight. Subsequent training phases have been conducted in India, including centrifuge training and microgravity familiarization in parabolic flights.

The medical screening protocols for Gaganyaan crew selection were developed by IAM with input from the Defence Research and Development Organisation. DRDO's Defence Institute of Physiology and Allied Sciences in Delhi has contributed research on human performance under extreme environmental stress, adapting its existing expertise in high-altitude and deep-diving physiology to the spaceflight context.

The 450-Crore Question

India's Mangalyaan cost roughly one-ninth of NASA's MAVEN mission, which entered Mars orbit the same month. That ratio has become both a point of pride and a framing device for Indian space ambitions. If ISRO can build interplanetary missions at a fraction of the global benchmark cost, can it do the same for space medicine research?

The answer is complicated. Some aspects of space medicine lend themselves to frugal engineering. Diagnostic instruments can be miniaturized and simplified. Telemedicine protocols can leverage India's existing strengths in information technology and remote healthcare delivery. Nutritional countermeasures can draw on India's deep knowledge of plant-based nutrition and traditional dietary systems.

Other aspects resist cost compression. Simulating microgravity requires either access to an orbital platform, which India does not yet operate for human research, or expensive ground-based analogs like bed rest facilities. Radiation biology research requires particle accelerators or access to space-based experiments. These are capital-intensive capabilities that cannot be replicated through clever engineering alone.

ISRO's approach has been to build partnerships rather than duplicate infrastructure. The agency has cooperation agreements with NASA, ESA, and Roscosmos that include crew health research exchanges. India's membership in the International Space Exploration Coordination Group provides access to shared research roadmaps and data. The strategy is pragmatic: use India's own resources where they offer an advantage, and leverage international partnerships where the infrastructure costs would be prohibitive.

The Institute of Aerospace Medicine

IAM Bangalore is the nerve center of Indian space medicine. Located on the Indian Air Force campus at Vimanapura, the institute operates centrifuges, altitude chambers, and spatial disorientation simulators. For Gaganyaan, its capabilities have been expanded to include spaceflight-specific medical monitoring and crew health protocols.

The institute's strength lies in its integration of clinical medicine with operational aerospace requirements. IAM physicians are both researchers and flight surgeons, responsible for certifying pilots and astronauts as fit for duty. This dual role creates a direct feedback loop between research findings and operational standards, a model similar to what NASA's Johnson Space Center operates but adapted to Indian institutional structures.

For Gaganyaan, IAM has developed pre-flight baseline health protocols, in-flight monitoring systems, and post-flight rehabilitation programs. The in-flight monitoring is necessarily compact. Gaganyaan's orbital module is designed for a crew of three in a relatively small volume, leaving minimal space for medical equipment. Every diagnostic device must justify its mass and volume allocation, a constraint that favors the kind of miniaturized, multi-function instruments that Indian engineering excels at producing.

IAM has also invested in research on Indian-specific physiological baselines. Human physiology varies across populations, and spaceflight medical standards developed primarily on American and Russian astronaut cohorts may not perfectly translate to Indian crew members. Factors like typical body mass, cardiovascular baseline parameters, and dietary habits differ. Establishing Indian-specific reference ranges for spaceflight medical monitoring is a prerequisite for safe crew operations.

DRDO's Parallel Track

The Defence Research and Development Organisation operates a parallel research track that feeds into Gaganyaan's medical dimension. DRDO's involvement reflects the military origins of Indian space medicine and the practical reality that India's pool of spaceflight physiology expertise resides primarily in defence research institutions.

The Defence Institute of Physiology and Allied Sciences in Delhi has studied human performance at extreme altitudes, producing data on how the body adapts to hypoxia, cold, and physical stress at India's high-altitude military postings along the Himalayan border. Some of this research translates to spaceflight contexts. The body's response to reduced oxygen partial pressure at altitude shares mechanisms with physiological adaptation in spacecraft environments. Cardiovascular responses to environmental stress follow similar pathways whether the stressor is altitude or microgravity.

DRDO's Defence Food Research Laboratory in Mysore has developed space food for Gaganyaan. The challenge is producing nutritionally complete, shelf-stable meals that support bone and muscle health during spaceflight while meeting Indian dietary preferences. For a three-person crew on a seven-day mission, the food challenge is manageable. For a Mars-duration mission, nutritional countermeasures become a critical component of the medical strategy, and India's extensive food science capabilities offer a genuine advantage.

The Defence Bioengineering and Electromedical Laboratory in Bangalore has worked on life support system components, including CO2 scrubbing and environmental monitoring systems. Miniaturization and cost efficiency are inherent requirements for Indian defence systems, and these constraints align naturally with the mass and volume budgets of spacecraft design.

From Low Earth Orbit to Deep Space

Gaganyaan targets low Earth orbit for seven days. A Mars mission requires 2.5 years in deep space. The gap between these two objectives is enormous, but ISRO has historically built capabilities incrementally, each mission serving as a stepping stone for the next.

The progression from Chandrayaan-1 (lunar orbiter, 2008) to Chandrayaan-2 (lander attempt, 2019) to Chandrayaan-3 (successful landing, 2023) illustrates this approach. Each mission expanded ISRO's technical envelope while staying within institutional and budgetary constraints. A similar trajectory for crewed spaceflight would move from Gaganyaan in low Earth orbit to longer-duration orbital missions, then potentially to lunar operations, before deep space becomes feasible.

For space medicine, this incremental approach offers both advantages and limitations. Each crewed mission generates physiological data that informs the next. A seven-day Gaganyaan mission will produce Indian-specific baseline data on acute spaceflight adaptation. Longer missions would track the onset of bone loss, muscle atrophy, and cardiovascular changes. The data builds cumulatively.

The limitation is time. If ISRO follows a step-by-step progression, a crewed Mars-relevant mission may be decades away. Meanwhile, the medical questions that need answering for Mars are urgent. Bone loss rates, radiation dose limits, the adequacy of 0.38g, these questions do not wait for any single nation's space program to catch up.

India's likely role in the near term is as a contributor to international Mars medical research rather than as an independent Mars program. ISRO's cost-effective satellite and launch capabilities, its growing pool of aerospace medical expertise, and its willingness to pursue international partnerships position it as a valuable collaborator in the global effort to solve the biological challenges of deep-space travel.

The Cost-Effective Diagnostic Edge

Where India may make its most distinctive contribution to Mars space medicine is in diagnostic technology. The Indian medical technology sector has a track record of producing devices that deliver comparable performance to Western equivalents at a fraction of the cost. Portable ultrasound devices, point-of-care blood analysers, and compact physiological monitoring systems manufactured in India are already used in remote healthcare settings across the developing world.

For a Mars crew operating without access to a hospital for two and a half years, the ability to diagnose and monitor medical conditions with compact, reliable, low-power equipment is not a luxury. It is a survival requirement. Every kilogram saved on medical equipment is a kilogram available for food, water, or shielding. Every watt saved on power is a watt available for life support.

Indian firms and research institutions have developed portable diagnostic platforms that could be adapted for spaceflight use. The challenge is qualifying these devices for the space environment, radiation hardening electronics, ensuring reliability over multi-year missions, and validating performance under partial gravity conditions. This qualification process is expensive and time-consuming, but the underlying technology is sound and cost-competitive.

ISRO's own telemetry and remote monitoring expertise, honed through decades of satellite operations, also applies. Managing crew health on a Mars mission requires continuous data collection, onboard analysis, and selective transmission to Earth, a workflow that mirrors satellite health monitoring at a different biological scale.

Between Ambition and Biology

India's space program has consistently achieved more than external observers expected, often at costs that defied international benchmarks. Mangalyaan reached Mars. Chandrayaan-3 landed on the Moon's south pole. Gaganyaan will send Indians to orbit. Each milestone was built on the pragmatic philosophy that constraints breed ingenuity.

But the human body does not negotiate with engineering philosophy. Bone loss in microgravity follows the same rate regardless of the mission's budget. Cosmic rays do not distinguish between an astronaut launched from Sriharikota and one launched from Cape Canaveral. The biological challenges of a Mars mission are universal, and solving them requires data that can only be gathered through experiments that India is just beginning to build the infrastructure for.

The question for Indian space medicine is not whether it can contribute to solving these challenges. It already is, through Gaganyaan development, through IAM research, through DRDO's parallel work in extreme environment physiology. The question is whether the global Mars effort will be structured to include India's contributions and benefit from its distinctive strengths, particularly in cost-effective diagnostics and frugal system design.

A Mars crew's survival may ultimately depend not on the most expensive medical technology available, but on the most reliable, compact, and energy-efficient technology that can function for years without maintenance. That is a design challenge India knows well.